These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score. Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ. Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388 [Abstract] [Full Text] [Related]
8. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome. Aoki I, Higashi K, Homori M, Chikazawa H, Ishikawa K. Am J Hematol; 1990 Sep; 35(1):6-12. PubMed ID: 2389770 [Abstract] [Full Text] [Related]
11. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S. Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558 [Abstract] [Full Text] [Related]
12. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, Stacchini A, Morelli S, Fubini L, Gallo E. Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532 [Abstract] [Full Text] [Related]
15. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors. Aoki A, Shibata A. Hematol Pathol; 1992 Feb; 6(3):143-53. PubMed ID: 1429342 [Abstract] [Full Text] [Related]
16. Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects. Geissler D, Zwierzina H, Pechlaner C, Gaggl S, Schmalzl F, Konwalinka G, Braunsteiner H. Br J Haematol; 1989 Sep; 73(1):29-35. PubMed ID: 2679861 [Abstract] [Full Text] [Related]
17. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes. Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S. Haematologica; 1992 Sep; 77(2):142-5. PubMed ID: 1383105 [Abstract] [Full Text] [Related]